Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Can diffusion-weighted magnetic resonance imaging predict a high Gleason score of prostate cancer?

Shigemura K, Yamanaka N, Yamashita M.

Korean J Urol. 2013 Apr;54(4):234-8. doi: 10.4111/kju.2013.54.4.234. Epub 2013 Apr 16.

2.

Multiparametric 3T MRI for the prediction of pathological downgrading after radical prostatectomy in patients with biopsy-proven Gleason score 3 + 4 prostate cancer.

Gondo T, Hricak H, Sala E, Zheng J, Moskowitz CS, Bernstein M, Eastham JA, Vargas HA.

Eur Radiol. 2014 Dec;24(12):3161-70. doi: 10.1007/s00330-014-3367-7. Epub 2014 Aug 7.

PMID:
25100337
3.

Initial experience with identifying high-grade prostate cancer using diffusion-weighted MR imaging (DWI) in patients with a Gleason score ≤ 3 + 3 = 6 upon schematic TRUS-guided biopsy: a radical prostatectomy correlated series.

Somford DM, Hambrock T, Hulsbergen-van de Kaa CA, Fütterer JJ, van Oort IM, van Basten JP, Karthaus HF, Witjes JA, Barentsz JO.

Invest Radiol. 2012 Mar;47(3):153-8. doi: 10.1097/RLI.0b013e31823ea1f0.

PMID:
22293513
4.

Prostate cancer: role of pretreatment multiparametric 3-T MRI in predicting biochemical recurrence after radical prostatectomy.

Park JJ, Kim CK, Park SY, Park BK, Lee HM, Cho SW.

AJR Am J Roentgenol. 2014 May;202(5):W459-65. doi: 10.2214/AJR.13.11381.

PMID:
24758681
5.

Multiparametric magnetic resonance imaging for the assessment of extracapsular invasion and other staging parameters in patients with prostate cancer candidates for radical prostatectomy.

Lista F, Gimbernat H, Cáceres F, Rodríguez-Barbero JM, Castillo E, Angulo JC.

Actas Urol Esp. 2014 Jun;38(5):290-7. doi: 10.1016/j.acuro.2013.11.003. Epub 2014 Jan 1. English, Spanish.

PMID:
24387827
6.

Assessment of Prostate Cancer Aggressiveness by Use of the Combination of Quantitative DWI and Dynamic Contrast-Enhanced MRI.

Hötker AM, Mazaheri Y, Aras Ö, Zheng J, Moskowitz CS, Gondo T, Matsumoto K, Hricak H, Akin O.

AJR Am J Roentgenol. 2016 Apr;206(4):756-63. doi: 10.2214/AJR.15.14912. Epub 2016 Feb 22.

PMID:
26900904
7.
8.

A multivariable analysis of clinical factors predicting for pathological features associated with local failure after radical prostatectomy for prostate cancer.

D'Amico AV, Whittington R, Malkowicz SB, Schnall M, Tomaszewski J, Schultz D, Kao G, VanArsdalen K, Wein A.

Int J Radiat Oncol Biol Phys. 1994 Sep 30;30(2):293-302.

PMID:
7928457
9.

Does suspicion of prostate cancer on integrated T2 and diffusion-weighted MRI predict more adverse pathology on radical prostatectomy?

Borofsky MS, Rosenkrantz AB, Abraham N, Jain R, Taneja SS.

Urology. 2013 Jun;81(6):1279-83. doi: 10.1016/j.urology.2012.12.026. Epub 2013 Feb 8.

PMID:
23394882
10.

Magnetic resonance imaging‑directed biopsy improves the prediction of prostate cancer aggressiveness compared with a 12‑core transrectal ultrasound‑guided prostate biopsy.

Zhang J, Xiu J, Dong Y, Wang M, Han X, Qin Y, Huang Z, Cai S, Yuan X, Liu Q.

Mol Med Rep. 2014 May;9(5):1989-97. doi: 10.3892/mmr.2014.1994. Epub 2014 Feb 28.

PMID:
24584266
11.

[Capabilities of diffusion-weighted magnetic resonance imaging to evaluate the efficiency of treatment for prostate cancer].

Ridén TV, Revizonskaia AV.

Vestn Rentgenol Radiol. 2014 Mar-Apr;(2):38-44. Russian.

PMID:
25272722
12.

Prostate Cancer: Utility of Whole-Lesion Apparent Diffusion Coefficient Metrics for Prediction of Biochemical Recurrence After Radical Prostatectomy.

Rosenkrantz AB, Ream JM, Nolan P, Rusinek H, Deng FM, Taneja SS.

AJR Am J Roentgenol. 2015 Dec;205(6):1208-14. doi: 10.2214/AJR.15.14482.

13.

The predictive value of endorectal 3 Tesla multiparametric magnetic resonance imaging for extraprostatic extension in patients with low, intermediate and high risk prostate cancer.

Somford DM, Hamoen EH, Fütterer JJ, van Basten JP, Hulsbergen-van de Kaa CA, Vreuls W, van Oort IM, Vergunst H, Kiemeney LA, Barentsz JO, Witjes JA.

J Urol. 2013 Nov;190(5):1728-34. doi: 10.1016/j.juro.2013.05.021. Epub 2013 May 13.

PMID:
23680307
14.

Preoperative 3-Tesla multiparametric endorectal magnetic resonance imaging findings and the odds of upgrading and upstaging at radical prostatectomy in men with clinically localized prostate cancer.

Hegde JV, Chen MH, Mulkern RV, Fennessy FM, D'Amico AV, Tempany CM.

Int J Radiat Oncol Biol Phys. 2013 Feb 1;85(2):e101-7. doi: 10.1016/j.ijrobp.2012.08.032. Epub 2012 Oct 3.

15.

Prostate cancer recurrence after radical prostatectomy: the role of 3-T diffusion imaging in multi-parametric magnetic resonance imaging.

Panebianco V, Barchetti F, Sciarra A, Musio D, Forte V, Gentile V, Tombolini V, Catalano C.

Eur Radiol. 2013 Jun;23(6):1745-52. doi: 10.1007/s00330-013-2768-3. Epub 2013 Feb 2.

PMID:
23377546
16.

Predictors of unfavorable disease after radical prostatectomy in patients at low risk by D'Amico criteria: role of multiparametric magnetic resonance imaging.

Song SH, Pak S, Park S, Song C, Jeong IG, Choi HJ, Kim JK, Cho KS, Kim CS, Ahn H.

J Urol. 2014 Aug;192(2):402-8. doi: 10.1016/j.juro.2014.02.2568. Epub 2014 Mar 11.

PMID:
24631106
17.

PI-RADS version 2 for prediction of pathological downgrading after radical prostatectomy: a preliminary study in patients with biopsy-proven Gleason Score 7 (3+4) prostate cancer.

Woo S, Kim SY, Lee J, Kim SH, Cho JY.

Eur Radiol. 2016 Oct;26(10):3580-7. doi: 10.1007/s00330-016-4230-9. Epub 2016 Feb 4.

PMID:
26847042
18.

Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis.

Oto A, Yang C, Kayhan A, Tretiakova M, Antic T, Schmid-Tannwald C, Eggener S, Karczmar GS, Stadler WM.

AJR Am J Roentgenol. 2011 Dec;197(6):1382-90. doi: 10.2214/AJR.11.6861.

PMID:
22109293
19.

Accuracy of MRI-Targeted in-Bore Prostate Biopsy According to the Gleason Score with Postprostatectomy Histopathologic Control--a Targeted Biopsy-Only Strategy with Limited Number of Cores.

Garmer M, Busch M, Mateiescu S, Fahlbusch DE, Wagener B, Grönemeyer DH.

Acad Radiol. 2015 Nov;22(11):1409-18. doi: 10.1016/j.acra.2015.06.020. Epub 2015 Sep 3.

PMID:
26343218
20.

The value of ADC, T2 signal intensity, and a combination of both parameters to assess Gleason score and primary Gleason grades in patients with known prostate cancer.

Nowak J, Malzahn U, Baur AD, Reichelt U, Franiel T, Hamm B, Durmus T.

Acta Radiol. 2016 Jan;57(1):107-14. doi: 10.1177/0284185114561915. Epub 2014 Dec 12.

PMID:
25505225

Supplemental Content

Support Center